Incyte Corp financial data

Symbol
INCY on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
1801 Augustine Cut Off, Wilmington, Delaware
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INCYTE INC (to 3/28/2003), INCYTE GENOMICS INC (to 2/25/2003), INCYTE PHARMACEUTICALS INC (to 4/18/2000)
Latest financial report
Q1 2024 - Apr 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 372 % -1.72%
Quick Ratio 4.5 % +0.67%
Debt-to-equity 30.9 % -0.52%
Return On Equity 14.7 % +94.5%
Return On Assets 11.3 % +94.7%
Operating Margin 17.1 % -13%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 225 M shares +0.65%
Common Stock, Shares, Outstanding 225 M shares +0.66%
Entity Public Float 11.7 B USD -17.6%
Common Stock, Value, Issued 224 K USD +0.45%
Weighted Average Number of Shares Outstanding, Basic 224 M shares +0.68%
Weighted Average Number of Shares Outstanding, Diluted 227 M shares +0.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.39 B USD +13.7%
Revenue from Contract with Customer, Excluding Assessed Tax 3.77 B USD +8.58%
Cost of Revenue 259 M USD +17.1%
Research and Development Expense 1.65 B USD +0.67%
Costs and Expenses 3.08 B USD +3.28%
Operating Income (Loss) 688 M USD +41%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.02 B USD +99.5%
Income Tax Expense (Benefit) 273 M USD +46.8%
Net Income (Loss) Attributable to Parent 745 M USD +130%
Earnings Per Share, Basic 3.33 USD/shares +128%
Earnings Per Share, Diluted 3.3 USD/shares +128%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.35 B USD +18.6%
Inventory, Net 63.6 M USD +55.7%
Assets, Current 4.85 B USD +22.1%
Deferred Income Tax Assets, Net 667 M USD +34.7%
Property, Plant and Equipment, Net 720 M USD -2.93%
Goodwill 156 M USD 0%
Other Assets, Noncurrent 47.4 M USD +129%
Assets 7.14 B USD +23.1%
Accounts Payable, Current 164 M USD +195%
Employee-related Liabilities, Current 89.1 M USD +5.18%
Accrued Liabilities, Current 1.1 B USD +33.5%
Liabilities, Current 1.4 B USD +38.8%
Operating Lease, Liability, Noncurrent 14.3 M USD +1.24%
Other Liabilities, Noncurrent 151 M USD +27.6%
Liabilities 1.74 B USD +30.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.17 M USD -129%
Retained Earnings (Accumulated Deficit) 330 M USD
Stockholders' Equity Attributable to Parent 5.39 B USD +20.9%
Liabilities and Equity 7.14 B USD +23.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 219 M USD
Net Cash Provided by (Used in) Financing Activities -12.4 M USD -410%
Net Cash Provided by (Used in) Investing Activities -73.1 M USD -156%
Common Stock, Shares Authorized 400 M shares 0%
Common Stock, Shares, Issued 225 M shares +0.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.35 B USD +18.6%
Deferred Tax Assets, Valuation Allowance 2.1 B USD +344%
Deferred Tax Assets, Gross 2.77 B USD +185%
Operating Lease, Liability 20 M USD -10.5%
Depreciation 60.1 M USD +29.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 718 M USD +95%
Lessee, Operating Lease, Liability, to be Paid 22.6 M USD -10.6%
Property, Plant and Equipment, Gross 1 B USD +3.67%
Operating Lease, Liability, Current 4.78 M USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.41 M USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.51 M USD -28.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -159 M USD -378%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.67 M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.89 M USD +41.7%
Deferred Tax Assets, Operating Loss Carryforwards 326 M USD +79.2%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -139 M USD -325%
Current Income Tax Expense (Benefit) 396 M USD +201%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 69.1 M USD -5.33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.9 M USD +90.9%
Operating Lease, Payments 9.4 M USD -20.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 48.1 M USD +26.1%
Current Federal Tax Expense (Benefit) 344 M USD +282%
Amortization of Intangible Assets 22.5 M USD +4.65%
Depreciation, Depletion and Amortization 21.9 M USD +14.2%
Deferred Tax Assets, Net of Valuation Allowance 672 M USD +34.3%
Share-based Payment Arrangement, Expense 222 M USD +12.3%
Deferred State and Local Income Tax Expense (Benefit) -19.6 M USD -429%
Interest Expense 2.51 M USD +2.32%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%